How many insider trades does FilingIQ track for SGHT?

FilingIQ tracks 232 Form 4 insider transactions for SGHT (Sight Sciences, Inc.), covering filings from Jul 19, 2021 onwards. 8 of those were filed in the last 90 days.

Are SGHT insiders net buyers or net sellers?

Across the full Form 4 history for SGHT, 43 transactions (19%) were open-market purchases and 77 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does SGHT insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is SGHT in?

Sight Sciences, Inc. (SGHT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $286.04M.

SGHT insider trading

Healthcare

Sight Sciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

232

Last 90 days

Buys / sells

19% / 33%

Market cap

$286.04M

About Sight Sciences, Inc.

Sight Sciences, Inc., an ophthalmic medical device company, focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of eye prevalent diseases. The company operates in two segments, Surgical Glaucoma and Dry Eye. Its products include OMNI surgical system, an implant-free, handheld, single-use, therapeutic technology that enables ophthalmic surgeons to perform a comprehensive procedure indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma, as well as for the catheterization and transluminal viscodilation of Schlemm's canal and cutting of the trabecular meshwork to reduce intraocular pressure in adult patients with open-angle glaucoma; and SION surgical instrument, a bladeless manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The company also provides TearCare system, a dry eye device designed to melt and facilitate the removal of meibomian gland obstructions and restore gland functionality. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Company website: www.sightsciences.com

SGHT insider activity at a glance

FilingIQ has scored 232 insider transactions for SGHT since Jul 19, 2021. The most recent filing in our index is dated Apr 6, 2026.

Across the full history, 43 open-market purchases and 77 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on SGHT insider trades is 56.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live SGHT trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for SGHT?: FilingIQ tracks 232 Form 4 insider transactions for SGHT (Sight Sciences, Inc.), covering filings from Jul 19, 2021 onwards. 8 of those were filed in the last 90 days.
Are SGHT insiders net buyers or net sellers?: Across the full Form 4 history for SGHT, 43 transactions (19%) were open-market purchases and 77 (33%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does SGHT insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is SGHT in?: Sight Sciences, Inc. (SGHT) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $286.04M.

Methodology & sources

Every SGHT insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.